pharmadog
News
when
  • Latest
  • Archive
by source
  • All Sources
  • Sources Page
Jobs
department
  • Clinical
  • Regulatory
  • Medical Affairs
  • Commercial
  • R&D / Discovery
  • Biostatistics / Data
  • Manufacturing / CMC
  • Market Access
therapeutic area
  • Oncology
  • Immunology
  • Neuroscience
  • Cardiovascular
  • Metabolic
  • Rare Disease
  • Infectious Disease
location & type
  • Remote Only
  • US Only
  • California
  • Massachusetts
  • Internships
  • Phase 3 Roles
  • All Jobs →
Drugs
by stage
  • Marketed
  • Phase 3
  • Phase 2
  • Phase 1
  • Preclinical
browse
  • Most catalysts
  • Recently active
  • All drugs →
  • Companies
  • Patent cliff
Calendar
what
  • Trial readouts
  • PDUFA dates
  • Approvals
  • Earnings
when
  • Upcoming
  • Month grid
  • Recently passed
Sign InSubscribe
pharmadog

fetch the data · sniff the signal

Discover
  • Jobs
  • News
  • Drugs
  • Calendar
  • Companies
Hubs
  • Topics
  • Patent cliff
  • Publications
  • Readouts
Tools
  • Compare
  • Search
  • Bookmarks
Trust
  • About
  • Sources
  • Contact
Legal
  • Privacy
  • Terms
  • Pricing

© 2026 pharmadog.xyz

made by humans and a good dog

  • home
  • jobs
  • news
  • search
the cabinet

Drugs

6,918 products tracked · 6,918 matching

★ save view↓export CSV
phase
allMarketedPhase 3Phase 2Phase 1Preclinical
sort
catalystsrecentname
therapeutic area
allOncology1831Infectious Disease718Cardiology425Pulmonology396Immunology371Ophthalmology368Dermatology300Women's Health
viewlistcards
FLUDEOXYGLUCOSE F18
FLUDEOXYGLUCOSE F18 (FLUDEOXYGLUCOSE F18)
UNIV MICHIGAN
0 catalysts
FLUDROCORTISONE ACETATE
FLUDROCORTISONE ACETATE (FLUDROCORTISONE ACETATE)
IMPAX LABS
0 catalysts
FLUOCINOLONE ACETONIDE TOPICAL
FLUOCINOLONE ACETONIDE TOPICAL (FLUOCINOLONE ACETONIDE TOPICAL)
ACTAVIS LABS UT INC
0 catalysts
FLUOCINOLONE ACETONIDE TOPICAL SOLUTION USP, 0.01%
FLUOCINOLONE ACETONIDE TOPICAL SOLUTION USP, 0.01% (FLUOCINOLONE ACETONIDE TOPICAL SOLUTION USP, 0.01%)
ENCUBE ETHICALS
0 catalysts
← prev
page 85 of 231
next →
131
Pain89
Neurology1
FLUORESCITE
FLUORESCITE (FLUORESCEIN SODIUM)
ALCON LABS INC
0 catalysts
FLUOXETINE
FLUOXETINE (FLUOXETINE)
MICRO LABS
0 catalysts
FLUOXETINE HCL
FLUOXETINE HCL (FLUOXETINE HCL)
STRIDES PHARMA
0 catalysts
FLUTICASONE PROPIONATE AND SALMETEROL
FLUTICASONE PROPIONATE AND SALMETEROL (FLUTICASONE PROPIONATE AND SALMETEROL)
TEVA PHARM
0 catalysts
FLUVASTATIN
FLUVASTATIN (FLUVASTATIN)
TEVA PHARMS
0 catalysts
Preclinical
FMC-220
Solid Tumor
LG Chem Ltd
0 catalysts
Phase 1
FMT-XBI-302
Graft Versus Host Disease (GVHD)
Shenzhen UnknownBio Biotechnology Co Ltd
0 catalysts
Preclinical
FN-2012
Idiopathic Pulmonary Fibrosis
Faknostics LLC
0 catalysts
FOAMING HAND WASH
FOAMING HAND WASH (CHLORHEXIDINE GLUCONATE)
XTTRIUM
0 catalysts
Preclinical
FORCEM-23D
Duchenne Muscular Dystrophy
$DYNDyne Therapeutics, Inc.
0 catalysts
Phase 1
FORX-428
Metastatic Breast Cancer
FoRx Therapeutics AG
0 catalysts
FOSAPREPITANT
FOSAPREPITANT (FOSAPREPITANT)
DR REDDYS
0 catalysts
FOSTER AND THRIVE ALLERGY AND CONGESTION D
FOSTER AND THRIVE ALLERGY AND CONGESTION D (FEXOFENADINE HYDROCHLORIDE, PSEUDOEPHEDRINE HYDROCHLORIDE)
L PERRIGO CO
0 catalysts
Preclinical
FP-016
Unspecified Neurologic Disorders
Foresee Pharmaceuticals Co Ltd
0 catalysts
Preclinical
FP-017
Unspecified Neurologic Disorders
Foresee Pharmaceuticals Co Ltd
0 catalysts
Preclinical
FP-0210
Formosa Pharmaceuticals Inc
0 catalysts
Phase 2
FP-101
Vasomotor Symptoms of Menopause (Hot Flashes)
Fervent Pharmaceuticals LLC
0 catalysts
Phase 1
FPI-2068
Metastatic Colorectal Cancer
Fusion Pharmaceuticals Inc
0 catalysts
Phase 2
FPI-2265
Metastatic Castration-Resistant Prostate Cancer (mCRPC)
Fusion Pharmaceuticals Inc
0 catalysts
Phase 1
FS-120
Advanced Malignancy
invoX Pharma Ltd
0 catalysts
Preclinical
FT-002a-O
Castration-Resistant Prostate Cancer (CRPC)
AecorBio Inc
0 catalysts
Phase 1
FT-522
B-Cell Non-Hodgkin Lymphoma
$FATEFATE THERAPEUTICS INC
0 catalysts
Phase 1
FT-576
Refractory Multiple Myeloma
$FATEFATE THERAPEUTICS INC
0 catalysts
Phase 1
FT-819
Idiopathic Inflammatory Myopathy (IIM)
$FATEFATE THERAPEUTICS INC
0 catalysts
Phase 1
FT-825
Colorectal Cancer
$FATEFATE THERAPEUTICS INC
0 catalysts
Phase 1
FT-836
Breast Cancer
$FATEFATE THERAPEUTICS INC
0 catalysts